Six new medicines were recommended by the Danish Medicines Council in June

NICE recommends cemiplimab for recurrent or metastatic cervical cancer

Palko has issued six new drug recommendations

Finland adopts most medicines with added value

TLV publishes new pricing and reimbursement guidelines

The Danish Medicines Council launches national basis list for GPs

First JCA report published for Ojemda

NICE recommends first new NHS treatment in over 20 years for women with resistant ovarian cancer

The Danish Medicines Council and Amgros allow companies more time to propose alternative agreements

Nordic HTA cooperation (JNHB) extended for another five years